RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/ERP134892
下载链接
链接失效反馈官方服务：
资源简介：
To better understand the differences between different ALK inhibitors on ALK positive NSCL cell lines, we performed RNA-seq analysis on samples treated with 3 types of ALK inhibitors: Alectinib, Lorlatinib and Brigatinib
创建时间：
2023-10-13
